Related Experiment Video
Updated: Jan 24, 2026

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
Published on: December 14, 2014
Prenatal screening for pre-eclampsia: Frequently asked questions.
Dagmar Wertaschnigg1,2, Maya Reddy1,3, Ben W J Mol1,3
1Department of Obstetrics and Gynaecology, Monash University, Melbourne, Victoria, Australia.
Screening for pre-eclampsia using combined tests improves detection rates for preterm pre-eclampsia. Early aspirin treatment for screen-positive individuals significantly reduces severe and preterm forms of the condition.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Clinical Chemistry
Background:
- Current pre-eclampsia screening relies on early pregnancy history to identify high-risk individuals for low-dose aspirin therapy.
- This method has limitations in detecting preterm pre-eclampsia effectively.
Purpose of the Study:
- To review the clinical implementation of pre-eclampsia screening.
- To address management strategies for screening results.
- To answer frequently asked questions regarding screening and aspirin use.
Main Methods:
- Review of current guidelines and combined screening test methodologies.
- Analysis of biophysical and biochemical markers in screening.
- Evaluation of aspirin's efficacy in preventing preterm pre-eclampsia.
Main Results:
- Combined screening tests demonstrate superior detection rates for preterm pre-eclampsia compared to history-based methods.
- Aspirin administration to the 10% screen-positive group significantly reduces severe and preterm pre-eclampsia.
Conclusions:
- Combined screening offers improved detection of preterm pre-eclampsia.
- Targeted aspirin prophylaxis in screen-positive individuals is effective in reducing adverse outcomes.
- Clinical implementation requires clear guidelines for screening and management.
More Related Videos
Related Concept Videos
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Tracheostomy Care I: Pre-procedural Steps
Required Equipment
The equipment necessary for tracheostomy care includes:
Pre-mRNA Processing: RNA Splicing
Tracheostomy Suctioning I: Pre-Procedural Steps
Equipment Required
First, gather all necessary equipment: a sterile suction catheter, a sterile disposable container, sterile gloves, a towel or...

